ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma. This is an ...
This is a preview. Log in through your library . Abstract Cluster randomization trials with relatively few clusters have been widely used in recent years for evaluation of health-care strategies. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback